Abbvie Inc (NYSE:ABBV)

85.19
Delayed Data
As of Oct 30
 +4.52 / +5.60%
Today’s Change
62.55
Today|||52-Week Range
101.28
-3.78%
Year-to-Date
Is Drug Pricing Backlash a Serious Risk for Big Pharma Stocks?
8:22am / MotleyFool.com - Paid Partner Content
Friday Morning Market Highlights
Oct 30 / GuruFocus News - Paid Partner Content
5 No-Brainer Stocks to Buy if Donald Trump Wins in November
6:40am / MotleyFool.com - Paid Partner Content
AbbVie (ABBV) Q3 Earnings and Revenues Top Estimates
Oct 30 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Q3 2020 Earnings Call Transcript
6:01am / MotleyFool.com - Paid Partner Content
2 No-Brainer Dividend Stocks Yielding More Than 4%
Oct 30 / MotleyFool.com - Paid Partner Content
How AbbVie Beat Expectations in Q3
Oct 30 / MotleyFool.com - Paid Partner Content
Amgen (AMGN) Q3 Earnings Top, Prolia, Biosimilars Drive Sales
Oct 29 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Beats on Q3 Earnings & Sales, Ups 2020 Guidance
Oct 30 / Zacks.com - Paid Partner Content
2 Healthcare Dividend Stocks to Buy No Matter Who Wins the Election
Oct 29 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close80.67
Today’s open83.39
Day’s range83.39 - 86.13
Volume18,095,146
Average volume (3 months)7,250,863
Market cap$142.1B
Data as of 4:27pm ET, 10/30/2020

Growth & Valuation

Earnings growth (last year)+44.28%
Earnings growth (this year)+16.60%
Earnings growth (next 5 years)+6.31%
Revenue growth (last year)+1.57%
P/E ratio18.6
Price/Sales3.95
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.91-1.78%
BMYBristol-Myers Squibb+0.55+0.95%
LLYEli Lilly and Co-2.15-1.62%
NVONovo Nordisk-2.53-3.81%
Data as of 7:56pm ET, 10/30/2020

Financials

Next reporting dateJanuary 22, 2021
EPS forecast (this quarter)$2.90
Annual revenue (last year)$33.3B
Annual profit (last year)$7.8B
Net profit margin23.57%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
North Chicago, Illinois

Forecasts